Zacks: Analysts Expect National Health Investors, Inc. (NYSE: NHI) to Report Earnings of $ 1.12 per Share
Analysts predict that National Health Investors, Inc. (NYSE: NHI) will report earnings per share (EPS) of $ 1.12 for the current quarter, Zacks Investment Research reports. Two analysts estimated National Health Investors earnings, with estimates ranging from $ 0.93 to $ 1.38. National Health Investors reported earnings of $ 1.37 per share in the same quarter last year, suggesting a negative year-over-year growth rate of 18.2%. The company is expected to announce its next results on Monday, February 28.
On average, analysts expect National Health Investors to report annual earnings of $ 4.69 per share for the current year, with EPS estimates ranging from $ 4.44 to $ 5.07. For the next fiscal year, analysts expect the company to report earnings of $ 4.79 per share, with EPS estimates ranging from $ 4.41 to $ 5.46. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research companies that cover National Health Investors.
National Health Investors (NYSE: NHI) last reported its quarterly results on Monday, November 8. The REIT reported earnings of $ 0.67 per share (EPS) for the quarter, missing Zacks’ consensus estimate of $ 1.18 of ($ 0.51). National Health Investors had a net margin of 45.92% and a return on equity of 9.20%. The company posted revenue of $ 73.83 million in the quarter, compared to analysts’ expectations of $ 74.21 million. In the same quarter of the previous year, the company posted earnings per share of $ 1.42. The company’s turnover is down 12.4% compared to the same quarter last year.
INSA has been the subject of a number of recent analyst reports. TheStreet downgraded National Health Investors from a “b-” rating to a “c +” rating in a research report released on Friday, October 8. Truist lowered its price target on National Health Investors from $ 71.00 to $ 64.00 and set a “conservation” rating for the company in a research report released Thursday, September 23. Capital One Financial raised National Health Investors from an “equal weight” to an “overweight” rating in a research report released on Tuesday, November 9. Zacks Investment Research downgraded National Health Investors from a “hold” rating to a “sell” rating in a research report released on Tuesday, November 2. Finally, Truist Securities lowered its price target on National Health Investors from $ 71.00 to $ 64.00 and set a “custody” rating for the company in a research report released Thursday, September 23. Two analysts rated the stock with a sell rating, four issued a conservation rating, and one issued a buy rating for the stock. According to MarketBeat data, the stock has a consensus rating of “Hold” and an average price target of $ 68.29.
In addition, director Robert T. Webb acquired 1,500 shares of the company in a transaction dated Thursday, September 16. The stock was purchased at an average price of $ 57.50 per share, for a total value of $ 86,250.00. The transaction was disclosed in a legal file with the SEC, accessible through the SEC’s website. In addition, director Robert T. Webb acquired 2,000 shares of the company in a transaction dated Thursday, September 30. The stock was purchased at an average cost of $ 53.86 per share, for a total value of $ 107,720.00. Disclosure of this purchase can be found here. During the past ninety days, insiders have acquired 6,500 shares of the company valued at $ 350,030. 6.55% of the shares are currently held by insiders.
Several hedge funds have recently changed their holdings in the company. UBS Asset Management Americas Inc. increased its holdings of National Health Investors shares by 4.1% in the 3rd quarter. UBS Asset Management Americas Inc. now owns 190,959 real estate investment trust shares valued at $ 10,216,000 after purchasing an additional 7,454 shares during the period. Bank of New York Mellon Corp raised its holdings of National Health Investors shares by 1.4% in the 3rd quarter. Bank of New York Mellon Corp now owns 896,308 real estate investment trust shares valued at $ 47,952,000 after purchasing an additional 11,999 shares during the period. Wealth Quarterback LLC raised its holdings of National Health Investors shares by 427.1% in the 3rd quarter. Wealth Quarterback LLC now owns 4,544 real estate investment trust shares valued at $ 44,000 after purchasing an additional 3,682 shares during the period. Jane Street Group LLC acquired a new position in shares of National Health Investors in Q3 valued at approximately $ 966,000. Finally, Squarepoint Ops LLC acquired a new position in National Health Investors shares in Q3 valued at approximately $ 214,000. 63.79% of the shares are held by institutional investors and hedge funds.
NYSE: NHI shares traded up $ 0.76 on Wednesday, reaching $ 54.68. The company traded 2,617 shares, compared to its average volume of 312,752. National Health Investors has a 52-week low of $ 50.88 and a 52-week high of $ 78.56. The company has a 50-day moving average of $ 54.80. The company has a market cap of $ 2.51 billion, a price-to-earnings ratio of 17.48 and a beta of 0.93. The company has a quick ratio of 20.73, a current ratio of 20.73 and a debt ratio of 0.83.
The company also recently declared a quarterly dividend, which will be paid on Monday, January 31. Shareholders of record on Friday, December 31 will receive a dividend of $ 0.90 per share. The ex-dividend date for this dividend is Thursday, December 30. This represents a dividend of $ 3.60 on an annualized basis and a return of 6.58%. National Health Investors’ dividend payout ratio is currently 115.02%.
National Health Investors Company Profile
National Health Investors, Inc. is a real estate investment trust, engaged in sale and leaseback, joint venture, mortgage and mezzanine financing of senior housing and medical investments. Its portfolio includes leases, mortgages and other investments in independent residences, assisted living facilities, paying communities, senior campuses, skilled nursing facilities, specialty hospitals and medical office buildings.
Feature article: Differences between dynamic investing and long-term investing
Get a Free Copy of Zacks’ National Health Investor (NHI) Research Report
For more information on Zacks Investment Research’s research offerings, visit Zacks.com
This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team before publication. Please send any questions or comments about this story to [email protected]
Should You Invest $ 1,000 In National Health Investors Now?
Before you consider National Health Investors, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts quietly whisper to their clients to buy now before the broader market takes hold of … and National Health Investors was not on the list.
While National Health Investors currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here